FDA nod for Novartis Cushing's disease drug Signifor
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 08 Nov, 2012
Singapore: The US FDA's Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) has voted unanimously in support o...Read more
Chugai gets positive outcome from Actemra Subcutaneous Injection trials
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 17 May, 2016
Japanese pharmaceutical giant Chugai Pharmaceutical Co Ltd has announced that its Actemra Subcutaneous Injection (Actemr...Read more
Prosetta Biosciences, Takeda to co-discover drugs for neurodegenerative diseases
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 03 May, 2016
Prosetta Biosciences Inc. has entered into a Feasibility and First Right of Negotiation Agreement with Japan's Takeda Ph...Read more
FDA approves Lupin's new generic
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 23 Jun, 2016
Pharma Major Lupin announced that its US subsidiary, Gavis Pharmaceuticals LLC., (collectively Lupin) has received final...Read more
Gout therapeutics market clocks $988.7 mn in 2011
Drug Discovery | Analysis | By BioSpectrum Bureau | 1 Comment | 23 May, 2012
Singapore: GlobalData's analysis shows that the global gout therapeutics market grew at a compound annual growth rate (...Read more
Pfizer, Repligen to push spinal muscular atrophy program
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 07 Jan, 2013
Singapore: US-based Repligen has entered into an exclusive worldwide licensing agreement with Pfizer to advance Repligen...Read more
UK commits $1.6 bn to fight AIDS, TB, Malaria
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 24 Sep, 2013
Singapore: United Kingdom (UK) has committed to contrbute $1.6 billion to fight AIDS, Tuberculosis and Malaria. Ms Just...Read more
China firm Beigene raises $75 mn
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 18 Nov, 2014
Singapore: China based biotech firm developing targeted and immune-oncology therapeutics, BeiGene, has raised $75 millio...Read more
Johns Hopkins releases NCD policy briefs
Drug Discovery | Analysis | By BioSpectrum Bureau | 1 Comment | 05 Feb, 2013
Singapore: Johns Hopkins University's Institute for Applied Economics, Global Health and the Study of Business Enterpris...Read more
Suven gets patents for NCE in Canada, China and India
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 04 Feb, 2014
Bangalore: Suven Life Sciences received three product patents one each from Canada (2600271), China (CN 101544592B) and ...Read more
Gilead's cancer drug under FDA scrutiny
Drug Discovery | Regulatory | By BioSpectrum Bureau | 0 Comment | 15 Mar, 2016
Singapore: US Food and Drug Administration has raised alarm for Gilead Science's cancer medicine Zydelig (idelalisib) du...Read more
CytRx gets FDA nod Aldoxorubicin cancer trial
Drug Discovery | Regulatory | By BioSpectrum Bureau | 0 Comment | 10 May, 2013
Singapore: US-based CytRx, a biopharmaceutical R&D company specializing in oncology, reached an agreement with the U...Read more
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 11 Jan, 2016
Singapore: China based Zai Lab, an innovative biopharmaceutical company, has secured over $100 million in Series B finan...Read more
CSL files marketing plea for Privigen in Europe
Drug Discovery | Regulatory | By BioSpectrum Bureau | 0 Comment | 01 Jun, 2012
Singapore: Australian company CSL Behring has submitted a variation application to the European Medicines Agency (EMA) f...Read more
Orient, NanoCarrier sign deal for Nanoplatin trial
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 29 Nov, 2012
Singapore: Taiwan company Orient Europharma and Japan-based pharmaceutical company NanoCarrier have signed a new agreeme...Read more
Novogen's ovarian cancer drug set for trials in H1 2016
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 03 May, 2016
US-Australian drug discovery company, Novogen Limited has provided an update on progress regarding the development of Ca...Read more
Japanese scientist inch closer to Toxoplasma vaccine discovery
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 04 Nov, 2015
Tokyo: Toxoplasma gondii is a common parasite which causes the development of fatal encephalosis or pneumonia in immunod...Read more
Australia's Gordagen forays into Japan with Matsumoto's support
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 06 Jan, 2016
Tokyo: Gordagen Pharmaceuticals, an Australian company developing evidence-based nutraceuticals and pharmaceuticals, has...Read more